131 related articles for article (PubMed ID: 33431417)
1. Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis in Different Administration Intervals in Mouse Tuberculosis Models.
Zhu H; Fu L; Wang B; Chen X; Zhao J; Huang H; Lu Y
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431417
[TBL] [Abstract][Full Text] [Related]
2. Identifying Regimens Containing TBI-166, a New Drug Candidate against
Zhang Y; Zhu H; Fu L; Wang B; Guo S; Chen X; Liu Z; Huang H; Yang T; Lu Y
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061157
[TBL] [Abstract][Full Text] [Related]
3.
Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.
Swanson RV; Adamson J; Moodley C; Ngcobo B; Ammerman NC; Dorasamy A; Moodley S; Mgaga Z; Tapley A; Bester LA; Singh S; Grosset JH; Almeida DV
Antimicrob Agents Chemother; 2015; 59(6):3042-51. PubMed ID: 25753644
[TBL] [Abstract][Full Text] [Related]
5. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
[TBL] [Abstract][Full Text] [Related]
6. Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Diacon AH; De Jager VR; Dawson R; Narunsky K; Vanker N; Burger DA; Everitt D; Pappas F; Nedelman J; Mendel CM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988102
[TBL] [Abstract][Full Text] [Related]
7. Fully weekly antituberculosis regimen: a proof-of-concept study.
Kort F; Fournier Le Ray L; Chauffour A; Jarlier V; Lounis N; Andries K; Aubry A; Guglielmetti L; Veziris N
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32430417
[TBL] [Abstract][Full Text] [Related]
8. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.
Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z
Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321
[TBL] [Abstract][Full Text] [Related]
9. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
[TBL] [Abstract][Full Text] [Related]
10. Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.
Brunaugh AD; Walz A; Warnken Z; Pearce C; Munoz Gutierrez J; Koleng JJ; Smyth HDC; Gonzalez-Juarrero M
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0018622. PubMed ID: 35943265
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
Yoshimatsu T; Nuermberger E; Tyagi S; Chaisson R; Bishai W; Grosset J
Antimicrob Agents Chemother; 2002 Jun; 46(6):1875-9. PubMed ID: 12019103
[TBL] [Abstract][Full Text] [Related]
12. Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection.
Kaushik A; Ammerman NC; Tyagi S; Saini V; Vervoort I; Lachau-Durand S; Nuermberger E; Andries K
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745396
[TBL] [Abstract][Full Text] [Related]
13. Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
Ammerman NC; Swanson RV; Tapley A; Moodley C; Ngcobo B; Adamson J; Dorasamy A; Moodley S; Mgaga Z; Bester LA; Singh SD; Almeida DV; Grosset JH
J Antimicrob Chemother; 2017 Feb; 72(2):455-461. PubMed ID: 27798204
[TBL] [Abstract][Full Text] [Related]
14. Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
Ammerman NC; Swanson RV; Bautista EM; Almeida DV; Saini V; Omansen TF; Guo H; Chang YS; Li SY; Tapley A; Tasneen R; Tyagi S; Betoudji F; Moodley C; Ngcobo B; Pillay L; Bester LA; Singh SD; Chaisson RE; Nuermberger E; Grosset JH
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735562
[TBL] [Abstract][Full Text] [Related]
15. Preserved Efficacy and Reduced Toxicity with Intermittent Linezolid Dosing in Combination with Bedaquiline and Pretomanid in a Murine Tuberculosis Model.
Bigelow KM; Tasneen R; Chang YS; Dooley KE; Nuermberger EL
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690647
[TBL] [Abstract][Full Text] [Related]
16. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
Park SW; Tasneen R; Converse PJ; Nuermberger EL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
[TBL] [Abstract][Full Text] [Related]
17. Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.
Grosset JH; Tyagi S; Almeida DV; Converse PJ; Li SY; Ammerman NC; Bishai WR; Enarson D; Trébucq A
Am J Respir Crit Care Med; 2013 Sep; 188(5):608-12. PubMed ID: 23822735
[TBL] [Abstract][Full Text] [Related]
18. Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Saini V; Ammerman NC; Chang YS; Tasneen R; Chaisson RE; Jain S; Nuermberger E; Grosset JH
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936097
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
Zhang Z; Li T; Qu G; Pang Y; Zhao Y
Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
[TBL] [Abstract][Full Text] [Related]
20. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
